Association between the RAD51 135 G>C Polymorphism and Risk of Cancer: A Meta-Analysis of 19,068 Cases and 22,630 Controls

• Wei Wang ,

  Contributed equally to this work with: Wei Wang, Jia-Lin Li

  Affiliations Shanxi Zhendong Pharmaceutical Co. Ltd., Changzhi, Shanxi Province, China, Research Center of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China

  ⨯
• Jia-Lin Li ,

  Contributed equally to this work with: Wei Wang, Jia-Lin Li

  Affiliation Department of Radiology, Putuo District Central Hospital, Shanghai, PR China

  ⨯
• Xiao-Feng He,

  Affiliation Information Section, Peace Hospital of Changzhi Medical College, Changzhi, Shanxi Province, China

  ⨯
• An-Ping Li,

  Affiliation Shanxi Zhendong Pharmaceutical Co. Ltd., Changzhi, Shanxi Province, China

  ⨯
• Yong-Lin Cai,

  Affiliation Central Laboratory, Wuzhou Red Cross Hospital, Wuzhou, Guangxi Province, China

  ⨯
• Na Xu,

  Affiliation Department of Hematology, Nanfang Hospital of Southern Medical University, Guangzhou, Guangdong Province, China

  ⨯
• Shu-Mei Sun,

  Affiliation Department of Infection Management, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China

  ⨯
• Bing-Yi Wu

  * E-mail: wubingyi66@126.com

  Affiliation Research Center of Clinical Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China

  ⨯